ABBOTT has reported double digit
earnings per share (EPS) growth for
the 2012 third quarter.
According to Abbott its third-quarter
ongoing EPS is US$1.30, a
year-on-year increase of 10.2%.
The period also saw the company
clock a worldwide sales increase of
4.1%.
Abbott CEO Miles White also said
that the company now is “on track
to split into two separate leading
healthcare companies in Jan 2013”.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Oct 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Oct 12
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.